These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 445398)

  • 1. Leukocyte migration inhibition in vitro in bladder carcinoma.
    Lavergne JA; Lamm DL; Radwin HM; Harrington JT
    Cancer Res; 1979 Jun; 39(6 Pt 1):1985-8. PubMed ID: 445398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transitional cell carcinoma: circulating tumor antigen correlated with presence/absence of tumor (leukocyte migration assay).
    Bowen JG
    Natl Cancer Inst Monogr; 1978 Dec; (49):245-7. PubMed ID: 748778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukocyte migration inhibition assay in patients with bladder cancer.
    Schellhammer PF; Wright GL; Rosato FE; Faulconer RJ
    J Urol; 1979 Dec; 122(6):746-9. PubMed ID: 513216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Suppression of leukocyte migration in bladder cancer with tumor antigens before and after surgery].
    Borisenko ID; Novikov DK; Shein IA
    Urol Nefrol (Mosk); 1978; (2):26-9. PubMed ID: 644715
    [No Abstract]   [Full Text] [Related]  

  • 5. Some uses and limitations of immunologic testing in human patients.
    Lavergne JA
    Bol Asoc Med P R; 1981 Apr; 73(4):141-5. PubMed ID: 6946780
    [No Abstract]   [Full Text] [Related]  

  • 6. Indirect macrophage migration inhibition response to 3-M KCl extract of gastric carcinoma.
    Akiyoshi T; Koba F; Kawaguchi M; Miyazaki S; Tsuji H
    J Natl Cancer Inst; 1982 Aug; 69(2):345-7. PubMed ID: 6955541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin tests with soluble tumor membrane antigens in patients with transitional cell cancers.
    Hollinshead AC
    Natl Cancer Inst Monogr; 1978 Dec; (49):255-6. PubMed ID: 748779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of circulating cytotoxic lymphocytes against autologous tumors in patients with bladder cancer.
    Mizutani Y; Okada Y; Terachi T; Yoshida O
    J Urol; 1996 Mar; 155(3):888-92; discussion 892-4. PubMed ID: 8583600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro production of human antibodies against bladder cancer: characterization and diagnostic implications.
    Pizza G; De Vinci C
    J Exp Pathol; 1987; 3(4):335-46. PubMed ID: 2457663
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cell immunity indices in carcinoma of the gastrointestinal tract].
    Kurtenkov OA
    Vopr Onkol; 1976; 22(10):14-8. PubMed ID: 1014487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression of the generation of cell-mediated cytotoxicity by macrophage-like suppressor cells in bladder carcinoma patients.
    Spina CA; Dorey F; Vescera C; Brosman S; Fahey JL
    Cancer Res; 1981 Nov; 41(11 Pt 1):4324-30. PubMed ID: 6458353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The study on Thomsen-Friedenreich antigen in bladder tumor].
    Oda Y
    Hinyokika Kiyo; 1985 Mar; 31(3):407-18. PubMed ID: 3895852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of 3-hydroxyanthranilic acid-antigen on the migration of peripheral blood leukocytes in patients with bladder tumors].
    Korosteleva TA; Kliucharev BV; Skadova VM; Vorob'ev AV; Chebotkevich VN
    Vopr Onkol; 1987; 33(5):59-62. PubMed ID: 3296440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the nonspecific cellular immune response in patients with urinary bladder carcinoma. II. Immunodepressive effect of sera from bladder carcinoma.
    Nishio S; Horii A; Morikawa Y; Kawakita J; Nishijima T; Kishimoto T; Maekawa M
    Invest Urol; 1979 Mar; 16(5):342-5. PubMed ID: 429128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies against P53 protein in patients with transitional cell carcinoma of the bladder.
    Sanchez-Carbayo M; Chulia MT; Niveiro M; Aranda I; Mira A; Soria F
    Anticancer Res; 1999; 19(4C):3531-7. PubMed ID: 10629648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of leukocyte migration by tumor-associated antigen in soluble extracts of human hepatoma.
    Lee C; Chen S; Lin T
    Cancer Res; 1977 Mar; 37(3):918-21. PubMed ID: 189919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of the serum blocking factor assay in the diagnosis and treatment of bladder cancer].
    Xu JN; Li YT; Zhang ZY
    Zhonghua Wai Ke Za Zhi; 1985 Aug; 23(8):453-6, 508. PubMed ID: 4092537
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1663-76. PubMed ID: 3825815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monoclonal antibodies against transitional cell carcinoma assay tumor associated antigens in different grades bladder cancer patients].
    Zhang H; Zhao Z; Sun H
    Zhonghua Wai Ke Za Zhi; 1996 Sep; 34(9):560-2. PubMed ID: 9594163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.